As NextPlat and certain affiliates of Progressive Care and NextPlat currently own an aggregate of approximately 53% of the voting power of Progressive Care’s outstanding capital stock, including all of the outstanding shares of the Series B Preferred Stock, such approval is, as a practical matter, assured.